Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.38
CI's Cash to Debt is ranked higher than
59% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.56 vs. CI: 0.38 )
CI' s 10-Year Cash to Debt Range
Min: 0.32   Max: 2.11
Current: 0.38

0.32
2.11
Equity to Asset 0.20
CI's Equity to Asset is ranked lower than
53% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. CI: 0.20 )
CI' s 10-Year Equity to Asset Range
Min: 0.04   Max: 0.2
Current: 0.2

0.04
0.2
Interest Coverage 8.24
CI's Interest Coverage is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.28 vs. CI: 8.24 )
CI' s 10-Year Interest Coverage Range
Min: 8.24   Max: 10.27
Current: 8.24

8.24
10.27
F-Score: 7
Z-Score: 1.46
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 6.72
CI's Operating margin (%) is ranked higher than
84% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.65 vs. CI: 6.72 )
CI' s 10-Year Operating margin (%) Range
Min: -2.94   Max: 13.07
Current: 6.72

-2.94
13.07
Net-margin (%) 4.56
CI's Net-margin (%) is ranked higher than
91% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.08 vs. CI: 4.56 )
CI' s 10-Year Net-margin (%) Range
Min: -2.31   Max: 9.74
Current: 4.56

-2.31
9.74
ROE (%) 13.97
CI's ROE (%) is ranked higher than
91% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.83 vs. CI: 13.97 )
CI' s 10-Year ROE (%) Range
Min: -11.36   Max: 30.32
Current: 13.97

-11.36
30.32
ROA (%) 2.72
CI's ROA (%) is ranked higher than
62% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.18 vs. CI: 2.72 )
CI' s 10-Year ROA (%) Range
Min: -0.5   Max: 3.62
Current: 2.72

-0.5
3.62
ROC (Joel Greenblatt) (%) 148.63
CI's ROC (Joel Greenblatt) (%) is ranked higher than
74% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 134.04 vs. CI: 148.63 )
CI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -52.78   Max: 305.66
Current: 148.63

-52.78
305.66
Revenue Growth (%) 13.50
CI's Revenue Growth (%) is ranked higher than
71% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.70 vs. CI: 13.50 )
CI' s 10-Year Revenue Growth (%) Range
Min: -2.3   Max: 16.9
Current: 13.5

-2.3
16.9
EBITDA Growth (%) 7.50
CI's EBITDA Growth (%) is ranked higher than
75% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.20 vs. CI: 7.50 )
CI' s 10-Year EBITDA Growth (%) Range
Min: -24.3   Max: 112.2
Current: 7.5

-24.3
112.2
EPS Growth (%) 3.40
CI's EPS Growth (%) is ranked higher than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.00 vs. CI: 3.40 )
CI' s 10-Year EPS Growth (%) Range
Min: -32   Max: 79.5
Current: 3.4

-32
79.5
» CI's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

CI Guru Trades in Q3 2013

Steven Cohen 101,909 sh (New)
Richard Pzena 3,278,145 sh (+340.97%)
Ray Dalio 55,781 sh (+79.47%)
James Barrow 2,632,627 sh (+13.18%)
Dodge & Cox 5,629,670 sh (+2.18%)
Bill Frels 4,890 sh (+0.31%)
John Keeley 8,150 sh (-2.4%)
Ken Heebner 115,000 sh (-4.17%)
David Einhorn 4,644,415 sh (-6.63%)
Vanguard Health Care Fund 6,267,800 sh (-10.15%)
Jeremy Grantham 115,252 sh (-15.22%)
Larry Robbins 2,779,610 sh (-15.69%)
Paul Tudor Jones 6,200 sh (-40.95%)
Pioneer Investments 77,400 sh (-83.02%)
David Dreman 1,429 sh (-97.49%)
» More
Q4 2013

CI Guru Trades in Q4 2013

Lee Ainslie 917,549 sh (New)
Caxton Associates 100,000 sh (New)
Jim Simons 147,100 sh (New)
David Dreman 2,883 sh (+101.75%)
Pioneer Investments 142,400 sh (+83.98%)
Paul Tudor Jones 10,692 sh (+72.45%)
Jeremy Grantham 154,352 sh (+33.93%)
Richard Pzena 4,145,441 sh (+26.46%)
James Barrow 2,638,491 sh (+0.22%)
Ronald Muhlenkamp 60 sh (unchged)
Bill Frels 4,890 sh (unchged)
John Keeley 8,150 sh (unchged)
Ray Dalio Sold Out
Ken Heebner Sold Out
Larry Robbins 2,694,510 sh (-3.06%)
Vanguard Health Care Fund 6,064,200 sh (-3.25%)
Dodge & Cox 5,297,220 sh (-5.91%)
David Einhorn 4,211,230 sh (-9.33%)
Steven Cohen 4,204 sh (-95.87%)
» More
Q1 2014

CI Guru Trades in Q1 2014

Mario Gabelli 10,050 sh (New)
Ray Dalio 62,981 sh (New)
Steven Cohen 381,772 sh (+8981.16%)
Paul Tudor Jones 20,109 sh (+88.08%)
David Dreman 4,371 sh (+51.61%)
Richard Pzena 4,823,204 sh (+16.35%)
Vanguard Health Care Fund 6,702,300 sh (+10.52%)
James Barrow 2,796,688 sh (+6%)
Dodge & Cox 5,371,387 sh (+1.4%)
Bill Frels 4,890 sh (unchged)
John Keeley 8,150 sh (unchged)
David Einhorn 4,211,230 sh (unchged)
Lee Ainslie Sold Out
Caxton Associates Sold Out
Jim Simons Sold Out
Larry Robbins 2,060,010 sh (-23.55%)
Pioneer Investments 77,400 sh (-45.65%)
Jeremy Grantham 80,000 sh (-48.17%)
» More
Q2 2014

CI Guru Trades in Q2 2014

Joel Greenblatt 23,082 sh (New)
Jim Simons 14,100 sh (New)
David Dreman 5,425 sh (+24.11%)
Dodge & Cox 6,049,387 sh (+12.62%)
Richard Pzena 5,281,715 sh (+9.51%)
Larry Robbins 2,226,626 sh (+8.09%)
James Barrow 2,884,758 sh (+3.15%)
Mario Gabelli 10,050 sh (unchged)
John Keeley 8,150 sh (unchged)
Pioneer Investments 77,400 sh (unchged)
Bill Frels 4,500 sh (-7.98%)
Vanguard Health Care Fund 6,163,900 sh (-8.03%)
David Einhorn 3,096,230 sh (-26.48%)
Ray Dalio 27,081 sh (-57%)
Paul Tudor Jones 8,000 sh (-60.22%)
Jeremy Grantham 5,000 sh (-93.75%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2014-06-30 Reduce -8.03%0.13%$75.64 - $92.11 $ 94.4410%6163900
Joel Greenblatt 2014-06-30 New Buy0.03%$75.64 - $92.11 $ 94.4410%23082
Ray Dalio 2014-06-30 Reduce -57%0.02%$75.64 - $92.11 $ 94.4410%27081
David Dreman 2014-06-30 Add 24.11%0.01%$75.64 - $92.11 $ 94.4410%5425
Lee Ainslie 2014-03-31 Sold Out 1%$75.94 - $90.13 $ 94.4414%0
Vanguard Health Care Fund 2014-03-31 Add 10.52%0.15%$75.94 - $90.13 $ 94.4414%6702300
Ray Dalio 2014-03-31 New Buy0.04%$75.94 - $90.13 $ 94.4414%62981
David Dreman 2014-03-31 Add 51.61%0.01%$75.94 - $90.13 $ 94.4414%4371
Mario Gabelli 2014-03-31 New Buy$75.94 - $90.13 $ 94.4414%10050
Lee Ainslie 2013-12-31 New Buy1%$73.17 - $88.18 $ 94.4416%917549
Ray Dalio 2013-12-31 Sold Out 0.04%$73.17 - $88.18 $ 94.4416%0
David Dreman 2013-12-31 Add 101.75%0.01%$73.17 - $88.18 $ 94.4416%2883
Vanguard Health Care Fund 2013-09-30 Reduce -10.15%0.19%$72.12 - $84.27 $ 94.4421%6267800
David Dreman 2013-09-30 Reduce -97.49%0.13%$72.12 - $84.27 $ 94.4421%1429
Ray Dalio 2013-09-30 Add 79.47%0.02%$72.12 - $84.27 $ 94.4421%55781
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Cigna Corp

David Einhorn Comments on Cigna - Oct 24, 2012

At the recent Value Investing Congress, David updated our view of Green Mountain Coffee Roasters (GMCR), elaborated on our General Motors (GM) and Cigna (CI) theses, and disclosed our short position in Chipotle Mexican Grill (CMG).

Regarding CI, we discussed that it trades at a discount to the HMOs, which as a group trade at low multiples. We then illustrated that CI is a higher-quality business that generates superior and more stable returns on equity than its peer group. With a substantial emphasis on Administrative Services Only business, CI deserves a higher multiple closer to the business process outsourcing companies (such as ADP) than to the HMOs. CI also has a significant and growing Medicare Advantage business and a fast growing international business. Finally, we noted that since the vast majority of its customers are large and mid-sized enterprises, CI has much less exposure to the known risks of Obamacare including health care exchanges. In fact, Obamacare may provide a growth opportunity for the company because it may finally afford CI the opportunity to compete meaningfully in the in the individual segment of the market.
From Greenlight Capital's third quarter letter.


Check out David Einhorn latest stock trades

Top Ranked Articles about Cigna Corp

52-Week High Companies: Cigna, Seadrill, Harley-Davidson, Life Technologies and Vodafone Group
Weekly 52-week high companies: Cigna Corp (CI), Seadrill Ltd (SDRL), Harley-Davidson Inc. (HOG), Life Technologies Corp. (LIFE), and Vodafone Group PLC (VOD). Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 13.00
CI's P/E(ttm) is ranked higher than
94% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 18.50 vs. CI: 13.00 )
CI' s 10-Year P/E(ttm) Range
Min: 3.24   Max: 21.62
Current: 13

3.24
21.62
P/B 2.30
CI's P/B is ranked higher than
66% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.12 vs. CI: 2.30 )
CI' s 10-Year P/B Range
Min: 0.52   Max: 3.96
Current: 2.3

0.52
3.96
P/S 0.80
CI's P/S is ranked higher than
54% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.51 vs. CI: 0.80 )
CI' s 10-Year P/S Range
Min: 0.13   Max: 1.05
Current: 0.8

0.13
1.05
PFCF 14.00
CI's PFCF is ranked higher than
69% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.20 vs. CI: 14.00 )
CI' s 10-Year PFCF Range
Min: 1.8   Max: 149.61
Current: 14

1.8
149.61
EV-to-EBIT 9.04
CI's EV-to-EBIT is ranked higher than
86% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.66 vs. CI: 9.04 )
CI' s 10-Year EV-to-EBIT Range
Min: 3.4   Max: 18.3
Current: 9.04

3.4
18.3
PEG 1.38
CI's PEG is ranked higher than
86% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.79 vs. CI: 1.38 )
CI' s 10-Year PEG Range
Min: 0.34   Max: 2.9
Current: 1.38

0.34
2.9
Shiller P/E 18.70
CI's Shiller P/E is ranked higher than
83% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 34.63 vs. CI: 18.70 )
CI' s 10-Year Shiller P/E Range
Min: 2.63   Max: 22.68
Current: 18.7

2.63
22.68

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 10.28
CI's Price/Tangible Book is ranked higher than
69% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.54 vs. CI: 10.28 )
CI' s 10-Year Price/Tangible Book Range
Min: 0.94   Max: 27.98
Current: 10.28

0.94
27.98
Price/DCF (Projected) 1.10
CI's Price/DCF (Projected) is ranked higher than
71% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.22 vs. CI: 1.10 )
CI' s 10-Year Price/DCF (Projected) Range
Min: 0.29   Max: 1.92
Current: 1.1

0.29
1.92
Price/Median PS Value 1.36
CI's Price/Median PS Value is ranked higher than
57% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CI: 1.36 )
CI' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 1.85
Current: 1.36

0.41
1.85
Price/Peter Lynch Fair Value 0.89
CI's Price/Peter Lynch Fair Value is ranked higher than
97% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.41 vs. CI: 0.89 )
CI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.31   Max: 2.96
Current: 0.89

0.31
2.96
Price/Graham Number 2.38
CI's Price/Graham Number is ranked higher than
80% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. CI: 2.38 )
CI' s 10-Year Price/Graham Number Range
Min: 0.77   Max: 3.73
Current: 2.38

0.77
3.73
Earnings Yield (Greenblatt) 11.10
CI's Earnings Yield (Greenblatt) is ranked higher than
84% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.20 vs. CI: 11.10 )
CI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.5   Max: 29.5
Current: 11.1

5.5
29.5
Forward Rate of Return (Yacktman) 17.62
CI's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 30 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.49 vs. CI: 17.62 )
CI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.1   Max: 44.2
Current: 17.62

-3.1
44.2

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, HUM, AET » details
Traded in other countries:CGN.Germany
Cigna Corp was incorporated in the State of Delaware in 1981. It is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. In the U.S., the majority of these products and services are offered through employers and other groups and, in selected international markets. It offers supplemental health, life and accident insurance products and international health care coverage and services to businesses, governmental and non-governmental organizations and individuals. The Company's segments are Global Health Care, Group Disability and Life, Global Supplemental Benefits, Run-off Reinsurance and Other Operations including Corporate-owned Life Insurance. The Global Health Care aggregates two operating segments namely Commercial that includes the international health care business and Government. The Company's Global Health Care segment offers insured and self-funded medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs and other products and services that might be integrated to provide individuals with complete health care benefit programs. The Company's Group Disability and Life segment provides the insurance products and their related services such as group life insurance, long-term and short-term disability insurance, workers' compensation and disability case management, and accident and specialty insurance. The Global Supplemental Benefits segment is comprised of the international supplemental health, life and accident businesses as well as the Medicare supplement business acquired in 2012. This segment offers supplemental health, life and accident insurance products in the U.S. and selected international markets. With local licenses and partnerships in approximately 20 countries and jurisdictions, it is able to offer products and services to local citizens and in other international markets. These products and services are provided by subsidiaries of the Company, including foreign operating entities. Until 2000, The Company offered reinsurance coverage for part or all of the risks written by other insurance companies under life and annuity policies (both group and individual) and accident policies. The products and services related to these operations were offered by subsidiaries of Cigna Corporation. In 2000, the Company sold its U.S. individual life, group life and accidental death reinsurance businesses As of December 31, 2012, the Company's remaining exposures resulted primarily from its annuity reinsurance business, including its reinsurance of GMDB and GMIB contracts. Other Operations of the Company consists of: non-leveraged and leveraged corporate-owned life insurance; deferred gains recognized from the 1998 sale of the individual life insurance and annuity business and the 2004 sale of the retirement benefits business and run-off settlement annuity business.
» More Articles for CI

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlight: AmerisourceBergen, Huntsman, Johnson Controls, Cigna, and Foster Wheeler Jun 15 2014 
Greenlight Capital and David Einhorn's Top Five of the First Quarter May 20 2014 
Maintain a Healthy Portfolio with Aetna Mar 24 2014 
Aetna - Why You Shouldn’t Stop Caring About This Health Care Stock Despite ObamaCare Dec 16 2013 
Healthcare Plan Sector: Bumpy Ride for UAM Sep 22 2013 
52-Week High Companies: Cigna, Seadrill, Harley-Davidson, Life Technologies and Vodafone Group Sep 01 2013 
David Einhorn's Top 5 Second Quarter Positions Aug 16 2013 
comment on CI Mar 13 2013 
David Einhorn Comments on Cigna Oct 24 2012 
David Einhorn's Greenlight Capital Q3 Investor Letter Oct 24 2012 

More From Our Partners
How Will Netflix (NFLX) Stock React To New Competing Canadian Services? Aug 26 2014 - THESTREET

More From Other Websites
Wells Capital’s VanCronkhite on Investing in Mid-Caps (Audio) Aug 27 2014
Taking Stock: Mid-Caps, Rate Hikes, Best Buy Turnaround Aug 26 2014
Hospice Oversight May Come From Rare Bipartisan Health Bill Aug 24 2014
CIGNA CORP Files SEC form 8-K, Regulation FD Disclosure Aug 21 2014
Cigna Foundation Grant to Improve Health of Hartford, Conn. neighborhood Aug 18 2014
Cigna’s Proprietary Retail Exchange Launches Nationally Aug 14 2014
Cigna Sees Brighter Future, Several Growth Initiatives Aug 13 2014
Chekesha Kidd Joins Cigna as Head of Voluntary Benefits Organization Aug 13 2014
Fortegra Financial Earnings Beat, Down Y/Y; Outlook Retained Aug 12 2014
ObamaCare Enrollment Is Shrinking, Top Insurers Say Aug 11 2014
CIGNA CORP Financials Aug 08 2014
Annual Cigna Forum Brings Denver-Area Business Leaders Together to Explore Health Improvement and... Aug 07 2014
Cigna Corporation Announces Appearance at the Morgan Stanley Global Healthcare Conference Aug 06 2014
Will This Price Target Increase Help Cigna (CI) Stock Today? Aug 01 2014
US STOCKS-S&P500 index posts worst fall since April; indexes down for July Jul 31 2014
US STOCKS-S&P500 index posts worst fall since April; indexes down for July Jul 31 2014
US STOCKS-S&P 500 posts worst day since April; indexes down for month Jul 31 2014
US STOCKS-S&P 500 posts worst day since April; indexes down for month Jul 31 2014
US STOCKS-S&P 500 posts worst day since April; indexes down for month Jul 31 2014
US STOCKS-Wall St drops, S&P on track for worst day since April Jul 31 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK